Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/31/13
End: 09/07/16
Due: 09/07/17
Phase: N/A
Priority: Normal
Start: 03/31/11
End: 10/31/15
Due: 10/31/16
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Treatment of Advanced Gastrointestinal Cancer in a Phase I/II Trial With Modified Autologous MSC_apceth_101 | NCT02008539 | Apceth GmbH & Co. KG | user2@example.com | None | 2013-10-31 | 2016-09-07 | 2017-09-07 | - | - | 2025-07-14 |
| Tolerability and Efficacy of Intravenous Infusion of Autologous MSC_Apceth for the Treatment of Critical Limb Ischemia | NCT01351610 | Apceth GmbH & Co. KG | user2@example.com | None | 2011-03-31 | 2015-10-31 | 2016-10-31 | - | - | 2025-07-14 |